2021

1: Levey RE, Coulter FB, Scheiner KC, Deotti S, Robinson ST, McDonough L, Nguyen TT, Steendam R, Canney M, Wylie R, Burke LP, Dolan EB, Dockery P, Kelly HM, Ghersi G, Hennink WE, Kok RJ, O'Cearbhaill E, Duffy GP. Assessing the Effects of VEGF Releasing Microspheres on the Angiogenic and Foreign Body Response to a 3D Printed Silicone-Based Macroencapsulation Device. Pharmaceutics. 2021 Dec 4;13(12):2077. doi: 10.3390/pharmaceutics13122077. PMID: 34959358; PMCID: PMC8704798

2: Su X, Ramírez-Escudero M, Sun F, van den Dikkenberg JB, van Steenbergen MJ, Pieters RJ, Janssen BJC, van Hasselt PM, Hennink WE, van Nostrum CF. Internalization and Transport of PEGylated Lipid-Based Mixed Micelles across Caco-2 Cells Mediated by Scavenger Receptor B1. Pharmaceutics. 2021 Nov 26;13(12):2022. doi: 10.3390/pharmaceutics13122022. PMID: 34959304; PMCID: PMC8703698

3: van de Looij SM, Hebels ER, Viola M, Hembury M, Oliveira S, Vermonden T. Gold Nanoclusters: Imaging, Therapy, and Theranostic Roles in Biomedical Applications. Bioconjug Chem. 2022 Jan 19;33(1):4-23. doi: 10.1021/acs.bioconjchem.1c00475. Epub 2021 Dec 12. PMID: 34894666; PMCID: PMC8778645

4: Estapé Senti M, de Jongh CA, Dijkxhoorn K, Verhoef JJF, Szebeni J, Storm G, Hack CE, Schiffelers RM, Fens MH, Boross P. Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement. J Control Release. 2022 Jan;341:475-486. doi: 10.1016/j.jconrel.2021.11.042. Epub 2021 Dec 7. PMID: 34890719

5: Ter Braake D, Benne N, Lau CYJ, Mastrobattista E, Broere F. Retinoic Acid- Containing Liposomes for the Induction of Antigen-Specific Regulatory T Cells as a Treatment for Autoimmune Diseases. Pharmaceutics. 2021 Nov 17;13(11):1949. doi: 10.3390/pharmaceutics13111949. PMID: 34834364; PMCID: PMC8620283.

6: Dorst DN, Boss M, Rijpkema M, Walgreen B, Helsen MMA, Bos DL, van Bloois L, Storm G, Brom M, Laverman P, van der Kraan PM, Buitinga M, Koenders MI, Gotthardt M. Photodynamic Therapy Targeting Macrophages Using IRDye700DX- Liposomes Decreases Experimental Arthritis Development. Pharmaceutics. 2021 Nov 5;13(11):1868. doi: 10.3390/pharmaceutics13111868. PMID: 34834283; PMCID: PMC8621465

7: Rousou C, Schuurmans CCL, Urtti A, Mastrobattista E, Storm G, Moonen C, Kaarniranta K, Deckers R. Ultrasound and Microbubbles for the Treatment of Ocular Diseases: From Preclinical Research towards Clinical Application. Pharmaceutics. 2021 Oct 25;13(11):1782. doi: 10.3390/pharmaceutics13111782. PMID: 34834196; PMCID: PMC8624665

8: Jiskoot W, Hawe A, Menzen T, Volkin DB, Crommelin DJA. Ongoing Challenges to Develop High Concentration Monoclonal Antibody-based Formulations for Subcutaneous Administration: Quo Vadis? J Pharm Sci. 2022 Apr;111(4):861-867. doi: 10.1016/j.xphs.2021.11.008. Epub 2021 Nov 20. PMID: 34813800

9: Schuurmans CCL, Brouwer AJ, Jong JAW, Boons GPH, Hennink WE, Vermonden T. Hydrolytic (In)stability of Methacrylate Esters in Covalently Cross-Linked Hydrogels Based on Chondroitin Sulfate and Hyaluronic Acid Methacrylate. ACS Omega. 2021 Sep 28;6(40):26302-26310. doi: 10.1021/acsomega.1c03395. PMID: 34660989; PMCID: PMC8515582

10: Raes L, Pille M, Harizaj A, Goetgeluk G, Van Hoeck J, Stremersch S, Fraire JC, Brans T, de Jong OG, Maas-Bakker R, Mastrobattista E, Vader P, De Smedt SC, Vandekerckhove B, Raemdonck K, Braeckmans K. Cas9 RNP transfection by vapor nanobubble photoporation for <i>ex vivo</i> cell engineering. Mol Ther Nucleic Acids. 2021 Aug 19;25:696-707. doi: 10.1016/j.omtn.2021.08.014. PMID: 34589287; PMCID: PMC8463438

11: Caiazza C, Parisi S, Caiazzo M. Liver Organoids: Updates on Disease Modeling and Biomedical Applications. Biology (Basel). 2021 Aug 27;10(9):835. doi: 10.3390/biology10090835. PMID: 34571712; PMCID: PMC8470787

12: Mashayekhi V, Mocellin O, Fens MHAM, Krijger GC, Brosens LAA, Oliveira S. Targeting of promising transmembrane proteins for diagnosis and treatment of pancreatic ductal adenocarcinoma. Theranostics. 2021 Aug 25;11(18):9022-9037. doi: 10.7150/thno.60350. PMID: 34522225; PMCID: PMC8419040

13: Viola M, Piluso S, Groll J, Vermonden T, Malda J, Castilho M. The Importance of Interfaces in Multi-Material Biofabricated Tissue Structures. Adv Healthc Mater. 2021 Nov;10(21):e2101021. doi: 10.1002/adhm.202101021. Epub 2021 Sep 12. PMID: 34510824

14: Jarusintanakorn S, Phechkrajang C, Khongkaew P, Mastrobattista E, Yamabhai M. Determination of Chinese hamster ovary (CHO) cell densities and antibody titers from small volumes of cell culture supernatants using multivariate analysis and partial least squares regression of UV-Vis spectra. Anal Bioanal Chem. 2021 Sep;413(23):5743-5753. doi: 10.1007/s00216-021-03549-4. Epub 2021 Sep 2. PMID: 34476523; PMCID: PMC8437849

15: Jalink P, Caiazzo M. Brain Organoids: Filling the Need for a Human Model of Neurological Disorder. Biology (Basel). 2021 Aug 2;10(8):740. doi: 10.3390/biology10080740. PMID: 34439972; PMCID: PMC8389592

16: Driest PJ, Jong JAW, Smakman R, Moret ME, Verhaar MC, Hennink WE, Gerritsen KGF, van Nostrum CF. Correction to "Reactivity of (Vicinal) Carbonyl Compounds with Urea". ACS Omega. 2021 Jul 28;6(31):20719-20721. doi: 10.1021/acsomega.1c03307. Erratum for: ACS Omega. 2019 Jul 10;4(7):11928-11937. PMID: 34396017; PMCID: PMC8359153

17: Affandi AJ, Olesek K, Grabowska J, Nijen Twilhaar MK, Rodríguez E, Saris A, Zwart ES, Nossent EJ, Kalay H, de Kok M, Kazemier G, Stöckl J, van den Eertwegh AJM, de Gruijl TD, Garcia-Vallejo JJ, Storm G, van Kooyk Y, den Haan JMM. CD169 Defines Activated CD14⁺ Monocytes With Enhanced CD8⁺ T Cell Activation Capacity. Front Immunol. 2021 Jul 28;12:697840. doi: 10.3389/fimmu.2021.697840. PMID: 34394090; PMCID: PMC8356644

18: Lou B, Lau CYJ, Hennink WE, Mastrobattista E. Preparation of mRNA Polyplexes with Post-conjugated Endosome-Disruptive Peptides. Methods Mol Biol. 2021;2355:275-286. doi: 10.1007/978-1-0716-1617-8_21. PMID: 34386965

19: Evers MJW, van de Wakker SI, de Groot EM, de Jong OG, Gitz-François JJJ, Seinen CS, Sluijter JPG, Schiffelers RM, Vader P. Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles. Adv Healthc Mater. 2022 Mar;11(5):e2101202. doi: 10.1002/adhm.202101202. Epub 2021 Aug 11. PMID: 34382360

20: Neupane YR, Huang C, Wang X, Chng WH, Venkatesan G, Zharkova O, Wacker MG, Czarny B, Storm G, Wang JW, Pastorin G. Lyophilization Preserves the Intrinsic Cardioprotective Activity of Bioinspired Cell-Derived Nanovesicles. Pharmaceutics. 2021 Jul 9;13(7):1052. doi: 10.3390/pharmaceutics13071052. PMID: 34371743; PMCID: PMC8309024

21: Wei Y, Sun Y, Wei J, Qiu X, Meng F, Storm G, Zhong Z. Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo. J Control Release. 2021 Sep 10;337:521-529. doi: 10.1016/j.jconrel.2021.07.048. Epub 2021 Aug 2. PMID: 34352315

22: Qiu B, de Vries RJ, Caiazzo M. Direct Cell Reprogramming of Mouse Fibroblasts into Functional Astrocytes Using Lentiviral Overexpression of the Transcription Factors NFIA, NFIB, and SOX9. Methods Mol Biol. 2021;2352:31-43. doi: 10.1007/978-1-0716-1601-7_3. PMID: 34324178

23: Meijboom KE, Volpato V, Monzón-Sandoval J, Hoolachan JM, Hammond SM, Abendroth F, de Jong OG, Hazell G, Ahlskog N, Wood MJ, Webber C, Bowerman M. Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy. JCI Insight. 2021 Jul 8;6(13):e149446. doi: 10.1172/jci.insight.149446. PMID: 34236053; PMCID: PMC8410072

24: Pronk SD, Schooten E, Heinen J, Helfrich E, Oliveira S, van Bergen En Henegouwen PMP. Single Domain Antibodies as Carriers for Intracellular Drug Delivery: A Proof of Principle Study. Biomolecules. 2021 Jun 22;11(7):927. doi: 10.3390/biom11070927. PMID: 34206656; PMCID: PMC8301836

25: Nijen Twilhaar MK, Czentner L, van Nostrum CF, Storm G, den Haan JMM. Mimicking Pathogens to Augment the Potency of Liposomal Cancer Vaccines. Pharmaceutics. 2021 Jun 24;13(7):954. doi: 10.3390/pharmaceutics13070954. PMID: 34202919; PMCID: PMC8308965

26: Mastrobattista E. Formulation and delivery solutions for the next generation biotherapeutics. J Control Release. 2021 Aug 10;336:583-597. doi: 10.1016/j.jconrel.2021.06.029. Epub 2021 Jun 24. PMID: 34174354

27: Mast MP, Modh H, Champanhac C, Wang JW, Storm G, Krämer J, Mailänder V, Pastorin G, Wacker MG. Nanomedicine at the crossroads - A quick guide for IVIVC. Adv Drug Deliv Rev. 2021 Dec;179:113829. doi: 10.1016/j.addr.2021.113829. Epub 2021 Jun 24. PMID: 34174332

28: Liu M, Thijssen S, van Nostrum CF, Hennink WE, Garssen J, Willemsen LEM. Inhibition of cow's milk allergy development in mice by oral delivery of β-lactoglobulin-derived peptides loaded PLGA nanoparticles is associated with systemic whey-specific immune silencing. Clin Exp Allergy. 2022 Jan;52(1):137-148. doi: 10.1111/cea.13967. Epub 2021 Jul 1. PMID: 34145667

29: Sofias AM, De Lorenzi F, Peña Q, Azadkhah Shalmani A, Vucur M, Wang JW, Kiessling F, Shi Y, Consolino L, Storm G, Lammers T. Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders. Adv Drug Deliv Rev. 2021 Aug;175:113831. doi: 10.1016/j.addr.2021.113831. Epub 2021 Jun 15. PMID: 34139255; PMCID: PMC7611899

30: Van Hoeck J, Van de Vyver T, Harizaj A, Goetgeluk G, Merckx P, Liu J, Wels M, Sauvage F, De Keersmaecker H, Vanhove C, de Jong OG, Vader P, Dewitte H, Vandekerckhove B, Braeckmans K, De Smedt SC, Raemdonck K. Hydrogel-Induced Cell Membrane Disruptions Enable Direct Cytosolic Delivery of Membrane-Impermeable Cargo. Adv Mater. 2021 Jul;33(30):e2008054. doi: 10.1002/adma.202008054. Epub 2021 Jun 9. PMID: 34106486

31: Rooimans T, Minderhoud T, Leal N, Vromans H, van Nostrum C, van Hasselt P; Lipophilic Drug Delivery Despite Cholestasis Study Group. Novel Orally Formulated Mixed Micelles Optimize Vitamin K Absorption Under Bile-Deficient Conditions. Gastroenterology. 2021 Sep;161(3):1056-1059.e5. doi: 10.1053/j.gastro.2021.05.056. Epub 2021 Jun 4. PMID: 34090886

32: Bouzetos E, Ganar KA, Mastrobattista E, Deshpande S, van der Oost J. (R)evolution-on-a-chip. Trends Biotechnol. 2022 Jan;40(1):60-76. doi: 10.1016/j.tibtech.2021.04.009. Epub 2021 May 25. PMID: 34049723

33: Escudé Martinez de Castilla P, Tong L, Huang C, Sofias AM, Pastorin G, Chen X, Storm G, Schiffelers RM, Wang JW. Extracellular vesicles as a drug delivery system: A systematic review of preclinical studies. Adv Drug Deliv Rev. 2021 Aug;175:113801. doi: 10.1016/j.addr.2021.05.011. Epub 2021 May 18. PMID: 34015418

34: Reiniers MJ, de Haan LR, Reeskamp LF, Broekgaarden M, van Golen RF, Heger M. Analysis and Optimization of Conditions for the Use of 2',7'-Dichlorofluorescein Diacetate in Cultured Hepatocytes. Antioxidants (Basel). 2021 Apr 26;10(5):674. doi: 10.3390/antiox10050674. PMID: 33925917; PMCID: PMC8147027

35: Xenaki KT, Dorrestijn B, Muns JA, Adamzek K, Doulkeridou S, Houthoff H, Oliveira S, van Bergen En Henegouwen PM. Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice. Theranostics. 2021 Mar 13;11(11):5525-5538. doi: 10.7150/thno.57510. PMID: 33859761; PMCID: PMC8039960

36: Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, Crommelin DJA. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability. Int J Pharm. 2021 May 15;601:120586. doi: 10.1016/j.ijpharm.2021.120586. Epub 2021 Apr 9. PMID: 33839230; PMCID: PMC8032477

37: Kooijmans SAA, de Jong OG, Schiffelers RM. Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design. Adv Drug Deliv Rev. 2021 Jun;173:252-278. doi: 10.1016/j.addr.2021.03.017. Epub 2021 Mar 31. PMID: 33798644

38: Beltrán Hernández I, Kromhout JZ, Teske E, Hennink WE, van Nimwegen SA, Oliveira S. Molecular targets for anticancer therapies in companion animals and humans: what can we learn from each other? Theranostics. 2021 Feb 6;11(8):3882-3897. doi: 10.7150/thno.55760. PMID: 33664868; PMCID: PMC7914358

40: Sofias AM, Combes F, Koschmieder S, Storm G, Lammers T. A paradigm shift in cancer nanomedicine: from traditional tumor targeting to leveraging the immune system. Drug Discov Today. 2021 Jun;26(6):1482-1489. doi: 10.1016/j.drudis.2021.02.017. Epub 2021 Feb 19. PMID: 33617793; PMCID: PMC7611945

41: Dias LM, Sharifi F, de Keijzer MJ, Mesquita B, Desclos E, Kochan JA, de Klerk DJ, Ernst D, de Haan LR, Franchi LP, van Wijk AC, Scutigliani EM, Cavaco JEB, Tedesco AC, Huang X, Pan W, Ding B, Krawczyk PM, Heger M; Photodynamic Therapy Study Group. Attritional evaluation of lipophilic and hydrophilic metallated phthalocyanines for oncological photodynamic therapy. J Photochem Photobiol B. 2021 Mar;216:112146. doi: 10.1016/j.jphotobiol.2021.112146. Epub 2021 Jan 29. PMID: 33601256

42: de Haan LR, Verheij J, van Golen RF, Horneffer-van der Sluis V, Lewis MR, Beuers UHW, van Gulik TM, Olde Damink SWM, Schaap FG, Heger M, Olthof PB. Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid. Biomolecules. 2021 Feb 10;11(2):260. doi: 10.3390/biom11020260. PMID: 33578971; PMCID: PMC7916678

43: Wong CW, Wong E, Metselaar JM, Storm G, Wong TT. Liposomal drug delivery system for anti-inflammatory treatment after cataract surgery: a phase I/II clinical trial. Drug Deliv Transl Res. 2022 Jan;12(1):7-14. doi: 10.1007/s13346-021-00912-x. Epub 2021 Feb 10. PMID: 33569720

44: Bhandari C, Guirguis M, Savan NA, Shrivastava N, Oliveira S, Hasan T, Obaid G. What NIR photodynamic activation offers molecular targeted nanomedicines: Perspectives into the conundrum of tumor specificity and selectivity. Nano Today. 2021 Feb;36:101052. doi: 10.1016/j.nantod.2020.101052. Epub 2020 Dec 16. PMID: 33552231; PMCID: PMC7864390

45: van Genderen AM, Jansen K, Kristen M, van Duijn J, Li Y, Schuurmans CCL, Malda J, Vermonden T, Jansen J, Masereeuw R, Castilho M. Topographic Guidance in Melt-Electrowritten Tubular Scaffolds Enhances Engineered Kidney Tubule Performance. Front Bioeng Biotechnol. 2021 Jan 18;8:617364. doi: 10.3389/fbioe.2020.617364. PMID: 33537294; PMCID: PMC7848123

46: Grabowska J, Affandi AJ, van Dinther D, Nijen Twilhaar MK, Olesek K, Hoogterp L, Ambrosini M, Heijnen DAM, Klaase L, Hidalgo A, Asano K, Crocker PR, Storm G, van Kooyk Y, den Haan JMM. Liposome induction of CD8⁺ T cell responses depends on CD169⁺ macrophages and Batf3-dependent dendritic cells and is enhanced by GM3 inclusion. J Control Release. 2021 Mar 10;331:309-320. doi: 10.1016/j.jconrel.2021.01.029. Epub 2021 Jan 22. PMID: 33493613

47: Ojha T, Hu Q, Colombo C, Wit J, van Geijn M, van Steenbergen MJ, Bagheri M, Königs-Werner H, Buhl EM, Bansal R, Shi Y, Hennink WE, Storm G, Rijcken CJF, Lammers T. Lyophilization stabilizes clinical-stage core-crosslinked polymeric micelles to overcome cold chain supply challenges. Biotechnol J. 2021 Jun;16(6):e2000212. doi: 10.1002/biot.202000212. Epub 2021 Feb 11. PMID: 33484630; PMCID: PMC7611944

48: Grabowska J, Stolk DA, Nijen Twilhaar MK, Ambrosini M, Storm G, van der Vliet HJ, de Gruijl TD, van Kooyk Y, den Haan JMM. Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8⁺ T Cell Responses via CD169⁺ Macrophages and cDC1. Vaccines (Basel). 2021 Jan 16;9(1):56. doi: 10.3390/vaccines9010056. PMID: 33467048; PMCID: PMC7830461

49: Bagheri M, Fens MH, Kleijn TG, Capomaccio RB, Mehn D, Krawczyk PM, Scutigliani EM, Gurinov A, Baldus M, van Kronenburg NCH, Kok RJ, Heger M, van Nostrum CF, Hennink WE. <i>In Vitro</i> and <i>In Vivo</i> Studies on HPMA-Based Polymeric Micelles Loaded with Curcumin. Mol Pharm. 2021 Mar 1;18(3):1247-1263. doi: 10.1021/acs.molpharmaceut.0c01114. Epub 2021 Jan 19. PMID: 33464911; PMCID: PMC7927141

50: van den Berg AIS, Yun CO, Schiffelers RM, Hennink WE. Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic. J Control Release. 2021 Mar 10;331:121-141. doi: 10.1016/j.jconrel.2021.01.014. Epub 2021 Jan 13. PMID: 33453339

51: Najafi M, Habibi M, Fokkink R, Hennink WE, Vermonden T. LCST polymers with UCST behavior. Soft Matter. 2021 Mar 4;17(8):2132-2141. doi: 10.1039/d0sm01505a. PMID: 33439188

52: Negussie AH, de Ruiter QMB, Britton H, Donahue DR, Boffi Q, Kim YS, Pritchard WF, Moonen C, Storm G, Lewis AL, Wood BJ. Synthesis, characterization, and imaging of radiopaque bismuth beads for image-guided transarterial embolization. Sci Rep. 2021 Jan 12;11(1):533. doi: 10.1038/s41598-020-79900-z. PMID: 33436734; PMCID: PMC7804415

53: Schuurmans CCL, Mihajlovic M, Hiemstra C, Ito K, Hennink WE, Vermonden T. Hyaluronic acid and chondroitin sulfate (meth)acrylate-based hydrogels for tissue engineering: Synthesis, characteristics and pre-clinical evaluation. Biomaterials. 2021 Jan;268:120602. doi: 10.1016/j.biomaterials.2020.120602. Epub 2020 Dec 22. PMID: 33360302

54: Crommelin DJA, Anchordoquy TJ, Volkin DB, Jiskoot W, Mastrobattista E. Addressing the Cold Reality of mRNA Vaccine Stability. J Pharm Sci. 2021 Mar;110(3):997-1001. doi: 10.1016/j.xphs.2020.12.006. Epub 2020 Dec 13. PMID: 33321139; PMCID: PMC7834447

55: van Raath MI, Chohan S, Wolkerstorfer A, van der Horst CMAM, Limpens J, Huang X, Ding B, Storm G, van der Hulst RRWJ, Heger M. Treatment Outcome Measurement Instruments for Port Wine Stains: A Systematic Review of Their Measurement Properties. Dermatology. 2021;237(3):416-432. doi: 10.1159/000511438. Epub 2020 Dec 3. PMID: 33271556; PMCID: PMC8117375

56: Crommelin DJA, Volkin DB, Hoogendoorn KH, Lubiniecki AS, Jiskoot W. The Science is There: Key Considerations for Stabilizing Viral Vector-Based Covid-19 Vaccines. J Pharm Sci. 2021 Feb;110(2):627-634. doi: 10.1016/j.xphs.2020.11.015. Epub 2020 Nov 23. PMID: 33242452; PMCID: PMC7682479

57: Cui H, Shen Y, Schiffelers RM, Hennink WE. Transform nanomedicine with breakthrough thinking? J Control Release. 2021 Feb 10;330:1130-1131. doi: 10.1016/j.jconrel.2020.11.018. Epub 2020 Nov 13. PMID: 33189787

58: Scheiner KC, Maas-Bakker RF, van Steenbergen MJ, Schwendeman SP, Hennink WE, Kok RJ. Post-loading of proangiogenic growth factors in PLGA microspheres. Eur J Pharm Biopharm. 2021 Jan;158:1-10. doi: 10.1016/j.ejpb.2020.10.022. Epub 2020 Nov 3. PMID: 33152482

59: Wong CW, Metselaar JM, Storm G, Wong TT. A review of the clinical applications of drug delivery systems for the treatment of ocular anterior segment inflammation. Br J Ophthalmol. 2021 Dec;105(12):1617-1622. doi: 10.1136/bjophthalmol-2020-315911. Epub 2020 Oct 30. PMID: 33127826

60: Liang C, Bai X, Qi C, Sun Q, Han X, Lan T, Zhang H, Zheng X, Liang R, Jiao J, Zheng Z, Fang J, Lei P, Wang Y, Möckel D, Metselaar JM, Storm G, Hennink WE, Kiessling F, Wei H, Lammers T, Shi Y, Wei B. Π electron-stabilized polymeric micelles potentiate docetaxel therapy in advanced-stage gastrointestinal cancer. Biomaterials. 2021 Jan;266:120432. doi: 10.1016/j.biomaterials.2020.120432. Epub 2020 Oct 5. PMID: 33069116; PMCID: PMC7611946

61: Jiang L, Luirink J, Kooijmans SAA, van Kessel KPM, Jong W, van Essen M, Seinen CW, de Maat S, de Jong OG, Gitz-François JFF, Hennink WE, Vader P, Schiffelers RM. A post-insertion strategy for surface functionalization of bacterial and mammalian cell-derived extracellular vesicles. Biochim Biophys Acta Gen Subj. 2021 Apr;1865(4):129763. doi: 10.1016/j.bbagen.2020.129763. Epub 2020 Oct 14. PMID: 33065252

62: Hoogendoorn KH, Crommelin DJA, Jiskoot W. Formulation of Cell-Based Medicinal Products: A Question of Life or Death? J Pharm Sci. 2021 May;110(5):1885-1894. doi: 10.1016/j.xphs.2020.07.002. Epub 2020 Jul 7. PMID: 32649938.